Home
Grant Application
About Us
Prior Funding
Copyright 2008-2015 - Feldstein Medical Foundation, Inc.
PRIOR FUNDING
For questions or comments regarding this web site please contact the webmaster
855 Valley Road, Third Floor, Clifton, NJ 07013
"The relationship between cardiometabolic risk factors and enterolignans
(enterolactone and enterodiol)"
Principal Investigator: Dr. Jeanette Beasley
Institution: Albert Einstein College of Medicine / NYU School of Medicine

Polyphenols are plant metabolites rich in fruit, vegetables, legumes, cereals,
cocoa/chocolate, coffee, tea, and wine. Due to their high antioxidant potential,
they have more recently been considered as agents for preventing and treating
oxidative stress-related diseases, including cardiovascular disease.
This project examines eight selected polyphenols (enterolactone, enterodiol,
resveratrol, daidzein, equol, naringenin, hesperetin, and quercetin) having
preliminary evidence of associations with obesity and other cardio-metabolic risk
factors in prior studies. It also provides the long-term potential to examine how
selected polyphenols relate to other health conditions, such as diabetes and
cancer in order to better understand the mechanisms by which polyphenols
influence chronic disease risk.

The above project description is supplied by the Principal Investigator